Although medication adherence is an important factor affecting treatment outcomes, many diabetic patients have yet to achieve acceptable adherence.
Objective
Measuring the potential of a mobile application to improve medication adherence and glycated hemoglobin (HbA1c) in patients with type 2 diabetes, consuming oral medicines to control diabetes.
Methods
Thirty cases in the control group received routine services. Thirty patients in the intervention group received a mobile application that provided audio alarms and a cartoon animation showing four gestures at the time of the medicine consumption, with three repeats after 10, 20, and 30 min. The measured outcomes were medication adherence and HbA1c.
Results
The medication adherence in the intervention group was significantly higher than the control group in all time points after starting the intervention (mean rank of 35.3 vs 25.7 at month 1; 37.0 vs 21.1 at month 2; 37.7 vs 20.5 at month 3, all p-values = 0.00). 0.28% reduction of the HbA1c was obtained for the intervention group (p-value = 0.02).
Conclusions
It is plausible to propose the utilization of the studied application as a means to improve medication adherence in patients with type 2 diabetes. Clinically meaningful reduction of HbA1c was not observed in this study.
MaglianoDJSacreJWHardingJL, et al.Young-onset type 2 diabetes mellitus - implications for morbidity and mortality. Nat Rev Endocrinol2020; 16(6): 321–331.
2.
KhanMABHashimMJKingJK, et al.Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health2020; 10(1): 107–111.
3.
GlovaciDFanWWongND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep2019; 21(4): 21.
PradeepaRMohanV. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol2021; 69(11): 2932–2938.
6.
KhatriBKayasthaMShresthaR, et al.Diabetes mellitus among adult outpatients visiting a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc2022; 60(251): 592–595.
7.
CamachoPPitaleSAbrairaC. Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus. Drugs Aging2000; 17(6): 463–476.
8.
St QuintonT. Applying the reasoned action approach and planning to understand diabetes self-management behaviors. Behav Sci2022; 12(10): 375.
9.
DaviesMJArodaVRCollinsBS, et al.IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract2022; 183: 109119.
10.
DoblerCC. Adherence to treatment. Breathe (Sheff)2021; 17(2): 210090.
11.
TangYWeissTLiuJ, et al.Metformin adherence and discontinuation among patients with type 2 diabetes: a retrospective cohort study. J Clin Transl Endocrinol2020; 20: 100225.
12.
EvansMEngbergSFaurbyM, et al.Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: a systematic literature review. Diabetes Obes Metab2022; 24(3): 377–390.
13.
ChapmanSCChanAH. Medication nonadherence-definition, measurement, prevalence, and causes: reflecting on the past 20 years and looking forwards. Front Pharmacol2025; 16: 1465059.
14.
WemrellMBennetLMerloJ. Understanding the complexity of socioeconomic disparities in type 2 diabetes risk: a study of 4.3 million people in Sweden. BMJ Open Diabetes Res Care2019; 7: e000749.
15.
MerchandB. Medication adherence: a key to effective treatment. Int Res J Pharm Pharmacol. 2023; 11(3): 1–3.
16.
FangKYBjeringHGinigeA. Simulating human carer with an avatar to improve medication adherence. Stud Health Technol Inform2017; 239: 35–40.
17.
KhorassaniFTellierSTsapepasD. Pharmacist's role in improving medication adherence in transplant recipients with comorbid psychiatric disorders. J Pharm Pract2019; 32(5): 568–578.
18.
HeidariPCrossWWellerC, et al.Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: a qualitative study. Int J Rheum Dis2019; 22(9): 1695–1705.
19.
SerperMLadnerDPCurtisLM, et al.Transplant regimen adherence for kidney recipients by engaging information technologies (TAKE IT): rationale and methods for a randomized controlled trial of a strategy to promote medication adherence among transplant recipients. Contemp Clin Trials2021; 103: 106294.
20.
CampagnaBRWeatherleyKShemeshE, et al.Adherence to medication during transition to adult services. Paediatr Drugs2020; 22(5): 501–509.
21.
MalasanosT. ANALYSIS: mobile phones integrated into diabetes management: a logical progression. J Diabetes Sci Technol2008; 2(1): 154–155.
22.
Aguado-LinaresPSendra-PorteroF. Gamification: basic concepts and applications in radiology. Radiologia2023; 65(2): 122–132.
23.
AwwadOAlMuhaissenSAl-NashwanA, et al.Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale. PLoS One2022; 17(10): e0275778.
24.
UchmanowiczBJankowskaEAUchmanowiczI, et al.Self-reported medication adherence measured with morisky medication adherence scales and its determinants in hypertensive patients aged ≥60 years: a systematic review and meta-analysis. Front Pharmacol2019; 10: 168.
25.
MoriskyDEGreenLWLevineDM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care1986; 24(1): 67–74.
26.
WhiteheadALJuliousSACooperCL, et al.Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res2016; 25(3): 1057–1073.
27.
MayberryRMDanielsPVWillockRJ, et al.Explaining poor medication adherence among adults with type 2 diabetes in an urban community health center. J Health Care Poor Underserved2020; 31(3): 1331–1346.
28.
O'ConorRArvanitisMWismerG, et al.Rationale and design of the regimen education and messaging in diabetes (REMinD) trial. Contemp Clin Trials2019; 83: 46–52.
29.
KreyenbuhlJRecordEJHimelhochS, et al.Development and feasibility testing of a smartphone intervention to improve adherence to antipsychotic medications. Clin Schizophr Relat Psychoses2019; 12(4): 152–167.
30.
GuerciBChananNKaurS, et al.Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes. Diabetes Ther2019; 10(2): 437–449.
31.
DenicolòSPercoPThöniS, et al.Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: a narrative review. J Diabetes Complications2021; 35(7): 107931.
32.
HomadyAAlbasheerOBajawiA, et al.Health-related quality of life among type 2 diabetes patients in Southern Province of Saudi Arabia using WHOQOL-BREF: a cross-section study. Curr Diabetes Rev2023; 19(7): e211222212099.
33.
De SimoniAFlemingLHollidayL, et al.Electronic reminders and rewards to improve adherence to inhaled asthma treatment in adolescents: a non-randomised feasibility study in tertiary care. BMJ Open2021; 11(10): e053268.
34.
BackesCMoyanoCRimaudC, et al.Digital medication adherence support: could healthcare providers recommend mobile health apps?Front Med Technol2021; 2: 616242.
35.
BradyVJMathew JosephNJuHH. Impact of gaming (gamification) on diabetes self-care behaviors and glycemic outcomes among adults with type 2 diabetes. Sci Diabetes Self Manag Care2023; 49(6): 493–511.
36.
HakamiAMAlmutairiBAlanaziAS, et al.Effect of Mobile apps on medication adherence of type 2 diabetes mellitus: a systematic review of recent studies. Cureus2024; 16(1): e51791.
37.
AlamsyahDHMulyaniYKaniawatiM. Review: The effect of medication reminder applications on medication compliance in type 2 diabetes mellitus patients. Medical Sains: Jurnal Ilmiah Kefarmasian2023; 8(4): 1449–1460.
